
Alpine Bio is a data-driven pharmaceutical niche company specializing in indication discovery within selected therapeutic areas. They leverage deep scientific insight and technology, including Generative AI, to innovate in addressing unmet medical needs and providing optimal solutions for patients and caregivers efficiently. The company analyzes projects and opportunities using data to make informed decisions. Alpine Bio focuses on growth through M&A, partnerships, and licensing, collaborating across the pharmaceutical value chain in areas such as manufacturing, regulatory affairs, clinical development, and pharmacovigilance. The company has a core team of founders and an extended network of 60-70 professionals available for projects. Alpine Bio is recognized as a first mover in applying Generative AI, combining leadership expertise in AI, technology, and pharmaceutical development and commercialization.

Alpine Bio is a data-driven pharmaceutical niche company specializing in indication discovery within selected therapeutic areas. They leverage deep scientific insight and technology, including Generative AI, to innovate in addressing unmet medical needs and providing optimal solutions for patients and caregivers efficiently. The company analyzes projects and opportunities using data to make informed decisions. Alpine Bio focuses on growth through M&A, partnerships, and licensing, collaborating across the pharmaceutical value chain in areas such as manufacturing, regulatory affairs, clinical development, and pharmacovigilance. The company has a core team of founders and an extended network of 60-70 professionals available for projects. Alpine Bio is recognized as a first mover in applying Generative AI, combining leadership expertise in AI, technology, and pharmaceutical development and commercialization.